| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:35298131 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0006665 | Sphingolipid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0006690 | Icosanoid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0006771 | Riboflavin metabolic process | Affects phenotype | PMID:35298131 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:35298131 |
| GO:0015939 | Pantothenate metabolic process | Affects phenotype | PMID:35298131 |
| GO:0018874 | Benzoate metabolic process | Affects phenotype | PMID:35298131 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0019521 | D-gluconate metabolic process | Affects phenotype | PMID:35298131 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:35298131 |
| GO:0019858 | Cytosine metabolic process | Affects phenotype | PMID:35298131 |
| GO:0030520 | Intracellular estrogen receptor signaling pathway | Affects phenotype | PMID:39365753 |
| GO:0030521 | Androgen receptor signaling pathway | Affects phenotype | PMID:39365753 |
| GO:0033559 | Unsaturated fatty acid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0042214 | Terpene metabolic process | Affects phenotype | PMID:35298131 |
| GO:0042431 | Indole metabolic process | Affects phenotype | PMID:35298131 |
| GO:0043651 | Linoleic acid metabolic process | Affects phenotype | PMID:35298131 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:36951524 |
| GO:0046083 | Adenine metabolic process | Affects phenotype | PMID:35298131 |
| GO:0046098 | Guanine metabolic process | Affects phenotype | PMID:35298131 |
| GO:0046110 | Xanthine metabolic process | Affects phenotype | PMID:35298131 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:35298131 |
| GO:0050810 | Regulation of steroid biosynthetic process | Affects phenotype | PMID:26781511 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:35298131 |
| GO:0120252 | Hydrocarbon metabolic process | Affects phenotype | PMID:35298131 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:36951524 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.